Search alternatives:
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
mean decrease » a decrease (Expand Search)
a large » _ large (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
mean decrease » a decrease (Expand Search)
a large » _ large (Expand Search)
-
13021
DataSheet_1_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.zip
Published 2022“…Due to the small number of patients in this study, these differences need to be further validated in a larger cohort.</p>…”
-
13022
Table_1_Mechanisms of Pond Expansion in a Rapidly Submerging Marsh.XLSX
Published 2021“…Previous studies propose that large ponds expand through a wind wave-driven positive feedback, where pond edge erosion rates increase with pond size, whereas biochemical processes control the formation and expansion of smaller ponds. …”
-
13023
Table_3_Mechanisms of Pond Expansion in a Rapidly Submerging Marsh.XLSX
Published 2021“…Previous studies propose that large ponds expand through a wind wave-driven positive feedback, where pond edge erosion rates increase with pond size, whereas biochemical processes control the formation and expansion of smaller ponds. …”
-
13024
Table_2_Mechanisms of Pond Expansion in a Rapidly Submerging Marsh.XLSX
Published 2021“…Previous studies propose that large ponds expand through a wind wave-driven positive feedback, where pond edge erosion rates increase with pond size, whereas biochemical processes control the formation and expansion of smaller ponds. …”
-
13025
-
13026
-
13027
-
13028
-
13029
Demographic data of patients with POAG and OHT.
Published 2024“…In total, 28 eyes were included in the study, with a mean patient age of 65.71±10.2 years. After IOP reduction, all biometric parameters, except CCT and ACD, exhibited a decrease without reaching statistical significance (all p>0.05). …”
-
13030
Participant and lab results flow.
Published 2025“…</p><p>Results</p><p>Women included in this analysis (N = 4,880) had a mean age of 40 years, > 98% were on antiretroviral therapy, and 61% had a CD4 count of ≥500 cells/µL. …”
-
13031
-
13032
Readout properties as a function of ensemble size <i>K</i>.
Published 2015“…<p>(A) The SVD decomposes population activity into a number of modes <i>m</i> with decreasing powers </p><p></p><p></p><p><mi>λ</mi><mi>m</mi><mn>2</mn></p><p></p><p></p>. …”
-
13033
Raw data.
Published 2023“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”
-
13034
Best fit and the values of the parameters.
Published 2023“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”
-
13035
Base-case analysis results without or with PAP.
Published 2023“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”
-
13036
Results of scenario analyses for cCRT population.
Published 2023“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”
-
13037
-
13038
Results of scenario analyses for sCRT population.
Published 2023“…The purpose of this study was to assess the cost-effectiveness of sugemalimab vs. placebo for consolidation treatment of stage III NSCLC from the perspective of the Chinese healthcare system.</p><p>Methods</p><p>A 3-state Markov model with a 3-week cycle length was performed to appraise the incremental cost-utility ratio (ICUR) of sugemalimab consolidation therapy based on the GEMSTONE-301 clinical trial over a 10-year time horizon. …”
-
13039
Baseline characteristics of participants.
Published 2025“…In the multivariable Cox regression analysis, eGFR > 120 mL/min ∙ 1.73 m<sup>2</sup> was associated with a decreased risk of dyslipidemia (HR: 0.35; 95% CI [0.34–0.36]). …”
-
13040
A major isoform of mitochondrial <i>trans</i>-2-enoyl-CoA reductase is dispensable for wax ester production in <i>Euglena gracilis</i> under anaerobic conditions
Published 2019“…<div><p>Under anaerobic conditions, <i>Euglena gracilis</i> produces a large amount of wax ester through mitochondrial fatty acid synthesis from storage polysaccharides termed paramylon, to generate ATP. …”